Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Ford US Sales Surge 14% In Q2 Despite EV Slump

USA TODAY · 2d
Ford reports Q2 sales gain of 14%; here's what led the gains
As Ford prepares to launch new pickup styles in the third quarter, it reveals big gains in pickups and SUVs during Q2.
Yahoo Finance · 2d
Ford Vs GM: Which Auto Stock is the Better Investment After Revealing Q2 Sales?
With the major domestic automakers releasing their vehicle sales for the second quarter, Ford (F) and General Motors (GM) were notable standouts, outperforming Tesla (TSLA).
AUTOPOST on MSN · 2d
Ford Q2 Sales Jump 14.2%, Market Share Rises Despite EV Slowdown
Ford Motor Company reported a significant 14.2% increase in sales for the second quarter of 2025. The automaker's market share increased to 14.3%, representing a 1.8% rise from the previous quarter. According to a statement released by Ford on Wednesday,
Zacks.com on MSN1d
Is Strong Demand for Pickups the Secret to Ford's Q2 Delivery Growth?
F's U.S. sales rise 14.2% in Q2, fueled by strong pickup and hybrid demand, lifting its market share to 14.3%.
20h
The story behind how Ford's push to be America's carmaker helped it top Toyota
The inside story of how Farley and Ford marketers made a last minute change of plans, that have Ford brand now leading U.S.
2don MSN
The Biggest Winners and Losers in Auto Sales in Q2 2025
Ford's SUV-heavy lineup enjoyed a strong second quarter, while Stellantis faltered across the board and several popular EVs ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy